CLINICAL_TRIALS
trial_result
· 2021-05-24
Clinical Trial Update: A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems [NA]
Summary
Post-market study evaluating Prodigy MRI and Proclaim Elite MR Conditional SCS systems for chronic pain has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott Medical Devices | Conditions: Chronic Pain | NA | Status: COMPLETED | Results posted: 2021-05-24